Bergen Online Quiz - Oct'18

20 Questions | Total Attempts: 448

SettingsSettingsSettings
Please wait...
Bergen Online Quiz - Oct

.


Questions and Answers
  • 1. 
    New Oxum spray is manufactured by ____________ technology
    • A. 

      A. Electric Current Assessment

    • B. 

      B. Electro Chemical Activation

    • C. 

      C. Both of the above

    • D. 

      D. None of the above

  • 2. 
    New Oxum spray is safe to use in humans as it is
    • A. 

      A. Non cytotoxic, non-Hepatotoxic and non-Nephrotoxic

    • B. 

      B. Non irritating

    • C. 

      C. Not contraindicated in pregnancy or in children

    • D. 

      D. All of the above

  • 3. 
    Enzocort is an _________ derivative of prednisolone
    • A. 

      A. Propaline

    • B. 

      B. Oxaline

    • C. 

      C. Benzaline

    • D. 

      D. None of the above

  • 4. 
    Gemcal MOM is smaller than CCM by
    • A. 

      A. 15.37 mm

    • B. 

      B. 5.13 mm

    • C. 

      C. 5.13 cm

    • D. 

      D. 20.50 mm

  • 5. 
    Nervmax is available as capsule         
    • A. 

      True

    • B. 

      False

  • 6. 
    Nervmax is for round the clock pain relief
    • A. 

      True

    • B. 

      False

  • 7. 
    New Oxum Spray is better than other options as it additionally
    • A. 

      A. Offers anti-ineffective action

    • B. 

      B. Offers wound debridement

    • C. 

      C. Moistens the wound area

    • D. 

      D. Accelerates the wound healing

  • 8. 
    NaOCl acts as catalyst for
    • A. 

      A. Phagocytosis

    • B. 

      B. Angiogenesis

    • C. 

      C. Haemostasis

    • D. 

      D. All of the above

  • 9. 
    Choose the correct statement about Ondem modified release technology
    • A. 

      A. Disintegrating agents dissolve and create channels and Fast dissolving granules swell & tablet disintegrates within 10 seconds

    • B. 

      B. Fast dissolving granules swell & tablet disintegrates and Disintegrating agents dissolve and create channels within 10 seconds

    • C. 

      C. Disintegrating agents swell & create channels and fast dissolving granules dissolve and tablet disintegrates within 10 seconds

  • 10. 
    Select the correct statement-Cholecalciferol in Uprise D3 60K, lowers the risk of:
    • A. 

      A. Diabetes

    • B. 

      B. Hypertension

    • C. 

      C. Back Pain

    • D. 

      D. All of the Above

  • 11. 
    As per “Indian Society of Endocrinology & Metabolism”, “Vitamin D sachet & Tablet Formulations reported disparity in Cholecaliceferol content” -
    • A. 

      True

    • B. 

      False

  • 12. 
    As per “Indian Society of Endocrinology & Metabolism”, “Uprise-D3 60K” offers Cholecaliferol content: -
    • A. 

      A. As per UK standards (90%-110%)

    • B. 

      B. As per USP standards (90%-110%)

    • C. 

      C. As per Australian standards (90%-110%)

    • D. 

      D. As per Egyptian standards (90%-110%)

  • 13. 
    Uprise D3 60K syrup is available in-
    • A. 

      A. Delicious Mango Flavor

    • B. 

      B. Delicious Pineapple flavor

    • C. 

      C. Delicious Pineapple Mango Mixed Flavor

    • D. 

      D. Delicious Orange Flavor

  • 14. 
    Uprise D3 60k Syrup is available in:
    • A. 

      20ml

    • B. 

      10ml

    • C. 

      30ml

    • D. 

      5ml

  • 15. 
    Uprise D3 400IU Syrup is available in:
    • A. 

      20ml

    • B. 

      10ml

    • C. 

      30ml

    • D. 

      5ml

  • 16. 
    How much % infants are Vitamin D insufficient-
    • A. 

      A. 94%

    • B. 

      B. 90%

    • C. 

      C. 77%

    • D. 

      D. 65%

  • 17. 
     Uprise D3 60K Syrup lowers the risk of influenza by-
    • A. 

      A. 50%

    • B. 

      B. 20%

    • C. 

      C. 30%

    • D. 

      D. 40%

  • 18. 
    Uprise D3 60K-
    • A. 

      A. Improves innate immunity & have no effect on asthma exacerbation

    • B. 

      B. Improves innate immunity & reduces asthma exacerbation

    • C. 

      C. Reduces asthma exacerbation & have no effect on innate immunity

    • D. 

      D. None of the Above

  • 19. 
    Which Statement is true for Gutgain-better stability of Sacchromyces Boulardii Vs lyophilised Sachromyces Boulardii
    • A. 

      A. 90% Greater GI Survival

    • B. 

      B. 60% Greater GI survival

    • C. 

      C. 30% Greater GI Survival

    • D. 

      D. 20% Greater GI Survival

Back to Top Back to top